Login / Signup

Response by Walters et al to Letter Regarding Article, " SOX17 Enhancer Variants Disrupt Transcription Factor Binding and Enhancer Inactivity Drives Pulmonary Hypertension".

Rachel WaltersEleni VasilakiMartin R WilkinsLan ZhaoChristopher J Rhodes
Published in: Circulation (2023)
Keyphrases
  • transcription factor
  • pulmonary hypertension
  • dna binding
  • binding protein
  • pulmonary artery
  • copy number
  • pulmonary arterial hypertension
  • genome wide identification
  • stem cells
  • coronary artery
  • genome wide